all-trans-undecaprenol

(2E,6E,10E,14E,18E,22E,26E,30E,34E,38E)-3,7,11,15,19,23,27,31,35,39,43-undecamethyltetratetraconta-2,6,10,14,18,22,26,30,34,38,42-undecaen-1-ol

TXKJNHBRVLCYFX-RDQGWRCRSA-N CHEBI:16591 0 Reactome links 1 studies

1 Observed studies

1 Observed diff profiles

0 Reactome pathways

Metabolite details

Identifier: TXKJNHBRVLCYFX-RDQGWRCRSA-N
InChI Key: TXKJNHBRVLCYFX-RDQGWRCRSA-N
IUPAC name: (2E,6E,10E,14E,18E,22E,26E,30E,34E,38E)-3,7,11,15,19,23,27,31,35,39,43-undecamethyltetratetraconta-2,6,10,14,18,22,26,30,34,38,42-undecaen-1-ol
Preferred name: all-trans-undecaprenol
INN name: —
Synonym: Undecaprenol
ChEBI: CHEBI:16591

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Effect of L-carnitine administration on lipid and metabolite content in sheep infraspinatus muscle after tendon release

Observed in differential profiles

Control_16.6_months_vs_Treatment_16.6_months